Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

2003 Vol. 21, No. 1

Cover
Display Method:
Clinical efficacy on chronic hepatitis B treated by lamivudine combination with oxymatrine
GU Jing-jing, Tian Gui-zhen
2003, (1): 3-4.
Abstract(2440) PDF (561KB)(943)
Abstract:
OBJECTIVE To study the efficacy and safety of lamivudine combination with oxymatrine in treating chronic hepatitis B.METHODS 67 patients were randomly divided into 2 groups.36 patients as a treatment group received 100mg·d-1,po,lamivudine combination...
2003, (1): 5-5.
Abstract(2703) PDF (164KB)(1297)
Abstract:
2003, (1): 6-7.
Abstract(2782) PDF (715KB)(442)
Abstract:
2003, (1): 8-10.
Abstract(2423) PDF (563KB)(1361)
Abstract:
2003, (1): 10-11.
Abstract(2395) PDF (543KB)(602)
Abstract:
2003, (1): 11-13.
Abstract(2512) PDF (824KB)(381)
Abstract:
2003, (1): 13-13.
Abstract(2402) PDF (306KB)(526)
Abstract:
2003, (1): 14-15.
Abstract(2594) PDF (329KB)(393)
Abstract:
2003, (1): 16-17.
Abstract(2336) PDF (326KB)(434)
Abstract:
Preparation and stability observation of electron medicinal membrane of roxithromycin
WANG Xiao-bo, WANG Jing-guo, XI Rong-gang, ZHANG Zhi-ran
2003, (1): 18-20.
Abstract(2875) PDF (648KB)(795)
Abstract:
OBJECTIVE To prepare electron medicinal membrane of roxithromycin. To develop a method for assay about electron medicinal membrane of roxithromycin and observe its stabilities.METHODS The electron medicinal membrane of roxithromycin was prepared with...
Evaluation of the correlation between in vitro release and in vitro absorption characteristics of nefopam sustained release capsules
YANG Hong-tu, CHANG Cui, NING De-e, XU Qun-ying, BI Dian-zhou
2003, (1): 20-23.
Abstract:
OBJECTIVE To evaluate the correlativity between in vitro release and in vivo absorption of nefopam sustained release capsules.METHODS The nefopam concentration in human plasma was determined by a high performance liquid chromatography method.Accordin...
2003, (1): 23-24.
Abstract(2170) PDF (710KB)(757)
Abstract:
2003, (1): 24-27.
Abstract:
2003, (1): 27-27,40.
Abstract(1960) PDF (512KB)(729)
Abstract:
2003, (1): 28-31.
Abstract(10560) PDF (546KB)(5293)
Abstract:
2003, (1): 32-35.
Abstract(3077) PDF (736KB)(2373)
Abstract:
2003, (1): 36-37.
Abstract(2137) PDF (477KB)(769)
Abstract:
2003, (1): 37-39.
Abstract:
2003, (1): 39-40.
Abstract(2841) PDF (508KB)(617)
Abstract:
2003, (1): 41-42.
Abstract(2711) PDF (549KB)(567)
Abstract:
2003, (1): 42-42.
Abstract(2383) PDF (250KB)(460)
Abstract:
2003, (1): 43-44.
Abstract(3142) PDF (310KB)(1044)
Abstract:
2003, (1): 45-46.
Abstract(2168) PDF (233KB)(511)
Abstract:
2003, (1): 47-48.
Abstract(1927) PDF (302KB)(536)
Abstract:
2003, (1): 48-49.
Abstract(2502) PDF (241KB)(616)
Abstract:
2003, (1): 49-51.
Abstract(2526) PDF (468KB)(421)
Abstract:
2003, (1): 51-52.
Abstract(2368) PDF (245KB)(437)
Abstract:
2003, (1): 52-52.
Abstract(2762) PDF (135KB)(550)
Abstract:
2003, (1): 53-55.
Abstract(2327) PDF (738KB)(2348)
Abstract:
2003, (1): 56-60.
Abstract(2565) PDF (596KB)(963)
Abstract: